Skip to main content
. 2025 Mar 10;93(4):e00591-24. doi: 10.1128/iai.00591-24

Fig 3.

Bar graphs depict cardiolipin levels in bacterial strains ATCC 27853 and 762 with and without SPH treatment. SPH significantly reduces cardiolipin levels in both strains. Statistical significance is indicated by asterisks.

Sphingosine induces a degradation of cardiolipin. (A) P. aeruginosa strains ATCC 27853 or 762 (1 × 107 CFU) were incubated in HEPES/saline (H/S, 132 mM NaCl, 20 mM HEPES [pH 7.0], 5 mM KCl, 1 mM CaCl2, 0.7 mM MgCl2, 0.8 mM MgSO4) for 20 min with 1 µM sphingosine (SPH) or left untreated, centrifuged, and lysed, and the cardiolipin content was determined by an enzyme kit from Abcam (#241036). Shown are the mean ± SD of five independent experiments; ***P <0.001, ANOVA. (B) P. aeruginosa strains ATCC 27853 or 762 (1 × 107 CFU) were labeled with 40 µCi [14C]acetate/100 mL TSB, washed, treated for 20 min with 1 µM sphingosine (SPH) or left untreated, pelleted, and extracted, and lipids were analyzed by TLC. Displayed are the mean ± SD, five independent experiments; ***P <0.001, ANOVA, post hoc Tukey test.